Rapid COVID-19 tests from White House not clinically approved for mass screening

The BinaxNow rapid antigen tests are designed to accurately detect COVID-19 infection in just 15 minutes

Millions of rapid COVID-19 tests that will be distributed for free by the Trump administration are not clinically approved for large-scale testing of the general population. Rather, Abbott Labs’ BinaxNow antigen test received emergency Food and Drug Administration approval for people showing symptoms of the disease. So, how will they be used in New Jersey? Senior Correspondent Brenda Flanagan reports.